Table 3.
Therapy Persistence for Antihypertensive, Antidepressive, and Antihyperlipidemic Therapy Classes by Study Group
| Study Group |
||||
|---|---|---|---|---|
| CDHP without Education (Referent) | CDHP with Education |
|||
| Therapy Class | Persistent, n/N (%) | Persistent, n/N (%) | OR (95% CI) | Adjusted OR* (95% CI) |
| Antihypertensive | 415/619 (67.0) | 253/356 (71.1) | 1.21 (0.90–1.63) | 1.18 (0.87–1.60) |
| Antidepressive | 277/464 (59.7) | 219/371 (59.0) | 0.97 (0.73–1.29) | 1.06 (0.79–1.42) |
| Antihyperlipidemic | 306/399 (76.7) | 177/239 (74.1) | 0.87 (0.60–1.26) | 0.84 (0.57–1.24) |
Adjusted for age, sex, use of home delivery for prescription drugs in 2007, and count of maintenance medications in 2007.
CDHP, consumer-directed health plan; CI, confidence interval; OR, odds ratio.